Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

SELL
$0.32 - $15.6 $4,732 - $230,708
-14,789 Reduced 57.81%
10,791 $3,000
Q2 2022

Aug 09, 2022

BUY
$0.56 - $1.25 $8,398 - $18,747
14,998 Added 141.73%
25,580 $15,000
Q1 2022

May 17, 2022

SELL
$0.86 - $1.86 $9,075 - $19,628
-10,553 Reduced 49.93%
10,582 $12,000
Q4 2021

Feb 17, 2022

SELL
$1.64 - $3.13 $82,895 - $158,208
-50,546 Reduced 70.52%
21,135 $35,000
Q3 2021

Nov 12, 2021

BUY
$2.67 - $5.09 $191,388 - $364,856
71,681 New
71,681 $206,000

About ReShape Lifesciences Inc.


  • Ticker RSLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,559,400
  • Market Cap $130M
  • Description
  • ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical sta...
More about RSLS
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.